These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31411964)

  • 1. Trends in Conservative Management for Low-risk Prostate Cancer in a Population-based Cohort of Australian Men Diagnosed Between 2009 and 2016.
    Ong WL; Evans SM; Evans M; Tacey M; Dodds L; Kearns P; Milne RL; Foroudi F; Millar J
    Eur Urol Oncol; 2021 Apr; 4(2):319-322. PubMed ID: 31411964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative management of low-risk prostate cancer among young versus older men in the United States: Trends and outcomes from a novel national database.
    Mahal AR; Butler S; Franco I; Muralidhar V; Larios D; Pike LRG; Zhao SG; Sanford NN; Dess RT; Feng FY; D'Amico AV; Spratt DE; Yu JB; Nguyen PL; Rebbeck TR; Mahal BA
    Cancer; 2019 Oct; 125(19):3338-3346. PubMed ID: 31251398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry.
    Weerakoon M; Papa N; Lawrentschuk N; Evans S; Millar J; Frydenberg M; Bolton D; Murphy DG
    BJU Int; 2015 Apr; 115 Suppl 5():50-6. PubMed ID: 25601201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease.
    Ruseckaite R; Beckmann K; O'Callaghan M; Roder D; Moretti K; Millar J; Evans S
    BMC Cancer; 2016 Aug; 16():607. PubMed ID: 27496055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring Variation in the Use of Conservative Management for Low-risk Prostate Cancer in the Veterans Affairs Healthcare System.
    Loeb S; Byrne NK; Wang B; Makarov DV; Becker D; Wise DR; Lepor H; Walter D
    Eur Urol; 2020 Jun; 77(6):683-686. PubMed ID: 32098730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of active surveillance uptake in a diverse population-based cohort of men with low-risk prostate cancer: The Treatment Options in Prostate Cancer Study (TOPCS).
    Xu J; Bock CH; Janisse J; Woo J; Cher ML; Ginsburg K; Yacoub R; Goodman M
    Cancer; 2024 May; 130(10):1797-1806. PubMed ID: 38247317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Navigate: a study protocol for a randomised controlled trial of an online treatment decision aid for men with low-risk prostate cancer and their partners.
    Schofield P; Gough K; Hyatt A; White A; Frydenberg M; Chambers S; Gordon LG; Gardiner R; Murphy DG; Cavedon L; Richards N; Murphy B; Quinn S; Juraskova I
    Trials; 2021 Jan; 22(1):49. PubMed ID: 33430950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal trends in the number of men electing for conservative management for low-risk prostate cancer in the United States.
    Al Hussein Al Awamlh B; Ballman KV; Ma X; Hu JC; Shoag JE
    Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):714-717. PubMed ID: 32661433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal Changes in Demographic and Clinical Characteristics of Men With Prostate Cancer Electing for Conservative Management in the United States.
    Al Hussein Al Awamlh B; Ma X; Scherr D; Hu JC; Shoag JE
    Urology; 2020 Mar; 137():60-65. PubMed ID: 31948677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of care and outcomes for men diagnosed with prostate cancer in Victoria: an update.
    Wang LL; Begashaw K; Evans M; Earnest A; Evans SM; Millar JL; Murphy DG; Moon D
    ANZ J Surg; 2018 Oct; 88(10):1037-1042. PubMed ID: 30047208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of South Australian-Victorian Prostate Cancer Health Outcomes Research Dataset.
    Ruseckaite R; Beckmann K; O'Callaghan M; Roder D; Moretti K; Zalcberg J; Millar J; Evans S
    BMC Res Notes; 2016 Jan; 9():37. PubMed ID: 26801762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of care achievements of the Prostate Cancer Outcomes Registry-Victoria.
    Sampurno F; Earnest A; Kumari PB; Millar JL; Davis ID; Murphy DG; Frydenberg M; Kearns PA; Evans SM
    Med J Aust; 2016 May; 204(8):319. PubMed ID: 27125808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large institutional variations in use of androgen deprivation therapy with definitive radiotherapy in a population-based cohort of men with intermediate- and high-risk prostate cancer.
    Ong WL; Foroudi F; Evans S; Millar J
    BJU Int; 2017 Nov; 120 Suppl 3():35-42. PubMed ID: 28749017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of localized prostate cancer following conservative management.
    Lu-Yao GL; Albertsen PC; Moore DF; Shih W; Lin Y; DiPaola RS; Barry MJ; Zietman A; O'Leary M; Walker-Corkery E; Yao SL
    JAMA; 2009 Sep; 302(11):1202-9. PubMed ID: 19755699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions.
    Loeb S; Zhou Q; Siebert U; Rochau U; Jahn B; Mühlberger N; Carter HB; Lepor H; Braithwaite RS
    Eur Urol; 2017 Dec; 72(6):899-907. PubMed ID: 28844371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
    Barocas DA; Cowan JE; Smith JA; Carroll PR;
    J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice-Level Adoption of Conservative Management for Prostate Cancer.
    Modi PK; Kaufman SR; Herrel LA; Dupree JM; Luckenbaugh AN; Skolarus TA; Hollenbeck BK; Shahinian VB
    J Oncol Pract; 2019 Oct; 15(10):e863-e869. PubMed ID: 31509481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evidence review of active surveillance in men with localized prostate cancer.
    Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J
    Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.
    Sathianathen NJ; Konety BR; Alarid-Escudero F; Lawrentschuk N; Bolton DM; Kuntz KM
    Eur Urol; 2019 Jun; 75(6):910-917. PubMed ID: 30425010
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.